Fernanda S. Correia-Melo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Fernanda S. Correia-Melo has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Acioly Luiz Tavares Lacerda
PRODAF—Programa de Transtornos Afetivos, Department of Psychiatry, Universidade Federal de São Paulo, Brazil
1 shared publication - Ana Paula Jesus-Nunes
Laboratory of Neuropsychopharmacology, Federal University of Bahia, Salvador, Brazil
1 shared publication - Ana Teresa Caliman-Fontes
Laboratório de Neuropsicofarmacologia, Serviço de Psiquiatria do Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil
1 shared publication - Breno Souza-Marques
Laboratório de Neuropsicofarmacologia, Serviço de Psiquiatria do Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil
1 shared publication - Cassio Santos-Lima
Laboratório de Neuropsicofarmacologia, Serviço de Psiquiatria do Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, BA, Brazil
1 shared publication Daniel H. Lins-Silva
Laboratório de Neuropsicofarmacologia, Serviço de Psiquiatria do Hospital Universitário Professor Edgard Santos, Universidade Federal da Bahia, Salvador, Brazil
1 shared publication
Latest Publications
- Open Access
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Does the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2023
- 1 January 2025
- Published by EDITORA SCIENTIFIC in Trends in Psychiatry and Psychotherapy
- Vol. 47 (AheadOfPri)
Open AccessDoes the intensity of dissociation predict antidepressant effects 24 hours after infusion of racemic ketamine or esketamine in treatment-resistant depression? A secondary analysis from a randomized controlled trial
Trends Psychiatry Psychother, vol.0, nAheadOfPrint, p.0-0, 2023